Zdrowie i gospodarka · 04/06/1997

FDA Requests Public Comment on Proposed Blood Product Information Collection

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to the shipment of blood products for manufacturing, with a focus on hepatitis B surface antigen (HBsAg) testing and donor reactivity.